Literature DB >> 20051928

Viral coinfections in children with invasive pneumococcal disease.

Benyachalee Techasaensiri1, Chonnamet Techasaensiri, Asuncion Mejías, George H McCracken, Octavio Ramilo.   

Abstract

BACKGROUND: Respiratory viruses contribute to the seasonal pattern of invasive pneumococcal disease (IPD), but the impact of viral coinfections on the clinical characteristics and outcomes of patients with IPD have not been well defined.
OBJECTIVE: This study was designed to describe and compare the clinical presentations and outcomes of patients with IPD with or without viral coinfections. DESIGN/
METHODS: Retrospective analyses of records of all children treated at Children's Medical Center Dallas (CMCD) for IPD from July 2005 to June 2008. Viral studies included viral direct fluorescent antibody staining and culture. For comparisons, patients were classified in 3 groups: with positive, negative, and no viral studies performed.
RESULTS: A total of 129 patients were admitted to CMCD with IPD during the 3 year study; 57% were male. Ages ranged from 2 months to 18 years (median 25 months) and 48% were <2 years. Viral studies were performed in 82 (63%) patients, and 28 (34%) had positive results. The most common viruses isolated were influenza (7, 25%), rhinoviruses (6, 21%), adenoviruses (6, 21%), and RSV (5, 18%). Peaks of positive viral studies occurred in February and November which coincided with the peak numbers of patients admitted with IPD. Of 6 with adenovirus coinfection, 5 were admitted to Pediatric Intensive Care Unit (PICU). The most common pneumococcal serotypes were 19A (41, 32.5%), 7F (14, 11%), and 23A (13, 10.3%). Pneumonia (42%), bacteremia (22%), and meningitis (17%) were the most common clinical syndromes. There were no differences in duration of fever before admission, maximum temperatures during hospitalization and white blood cell counts, duration of fever and hospitalization between patients with positive and negative viral studies, but there was a trend for patient with positive viral studies to be admitted to PICU more frequently and to have longer PICU stay. Three of the 6 patients who died had documented viral coinfections (2 adenovirus, 1 parainfluenza 3), and all 3 had no underlying conditions. The other 3 patients who died had no viral studies performed. Duration of treatment ranged from 1 to -210 days (median 14), with no differences among the groups.
CONCLUSIONS: Viral coinfections were common in children with IPD. Future prospective studies should include new PCR assays to characterize better the impact of viral coinfections in the occurrence and outcome of IPD.

Entities:  

Mesh:

Year:  2010        PMID: 20051928     DOI: 10.1097/INF.0b013e3181cdafc2

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  28 in total

1.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

Review 2.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

3.  The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Authors:  D S Klobassa; B Zoehrer; M Paulke-Korinek; U Gruber-Sedlmayr; K Pfurtscheller; V Strenger; A Sonnleitner; R Kerbl; B Ausserer; W Arocker; W Kaulfersch; B Hausberger; B Covi; F Eitelberger; A Vécsei; B Simma; R Birnbacher; H Kurz; K Zwiauer; D Weghuber; S Heuberger; F Quehenberger; H Kollaritsch; W Zenz
Journal:  Eur J Pediatr       Date:  2014-01-14       Impact factor: 3.183

Review 4.  Preventing and treating secondary bacterial infections with antiviral agents.

Authors:  Jonathan A McCullers
Journal:  Antivir Ther       Date:  2011

Review 5.  Viral Bacterial Interactions in Children: Impact on Clinical Outcomes.

Authors:  Alejandro Diaz-Diaz; Cristina Garcia-Maurino; Alejandro Jordan-Villegas; Jeffrey Naples; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2019-06       Impact factor: 2.129

6.  Effects of bacterial and viral co-infections of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014.

Authors:  Qing Song; Bao-Ping Xu; Kun-Ling Shen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia.

Authors:  Daniel M Weinberger; Zitta B Harboe; Cécile Viboud; Tyra G Krause; Mark Miller; Kåre Mølbak; Helle B Konradsen
Journal:  J Infect Dis       Date:  2013-07-30       Impact factor: 5.226

8.  Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States.

Authors:  Daniel M Weinberger; Lone Simonsen; Richard Jordan; Claudia Steiner; Mark Miller; Cécile Viboud
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

9.  Impact of influenza season and environmental factors on the clinical presentation and outcome of invasive pneumococcal disease.

Authors:  J Burgos; M N Larrosa; A Martinez; J Belmonte; J González-López; J Rello; T Pumarola; A Pahissa; V Falco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-12       Impact factor: 3.267

10.  The high burden of pneumonia on US emergency departments during the 2009 influenza pandemic.

Authors:  Wesley H Self; Marie R Griffin; Yuwei Zhu; William D Dupont; Tyler W Barrett; Carlos G Grijalva
Journal:  J Infect       Date:  2013-10-15       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.